Citation: | Zaya GERILI, LI Jingguang, WANG Yuxin, CUI Shiwei, ZHANG Lei, SUN Xin. Comparison of per- and polyfluoroalkyl substance exposure levels in neonatal cord blood between an e-waste recycling area and a general exposure area[J]. Journal of Environmental and Occupational Medicine, 2024, 41(8): 876-883. DOI: 10.11836/JEOM24013 |
Per- and polyfluoroalkyl substances (PFAS) are a class of persistent organic pollu-tants. Industrial production and consumer use of PFAS are the primary sources of exposure in urban areas. E-waste recycling activities are also a significant source of environmental PFAS exposure.
To compare exposure profiles between traditional and emerging PFAS in neonatal cord blood collected from an e-waste recycling area and a general exposure area characterized by modern economic development (hereafter referred to as general exposure area).
Based on a birth cohort study conducted in 2018, 85 pregnant women were recruited (36 participants from an e-waste recycling area and 49 participants from a general exposure area). Neonatal cord blood was collected at delivery. Ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was used to detect 28 common PFAS in the blood. A structured questionnaire was used to gather sociodemographic characteristics of the pregnant women. Mann-Whitney U tests were used to compare PFAS exposure levels in neonatal cord blood between the e-waste recycling area and the general exposure area. Multiple linear regression models were used to explore the influence of residing in the e-waste recycling area on neonatal PFAS exposure, with area as the independent variable and the natural logarithm of PFAS exposure levels as the dependent variable.
A total of 22 PFAS were positive in neonatal cord blood, of which 13 congeners were 100% detectable in the samples from both areas. The median ∑PFAS exposure levels in neonatal cord blood were 14.19 ng·mL−1 and 14.02 ng·mL−1 for the e-waste recycling area and the general exposure area, respectively, with linear perfluorooctanoic acid (L-PFOA) showing the highest median concentration (5.49 ng·mL−1 and 6.39 ng·mL−1, respectively). The results of Mann-Whitney U tests showed that the median exposure levels of long-chain perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUnDA), perfluorododecanoic acid (PFDoDA), and perfluorotridecanoic acid (PFTrDA), as well as emerging alternatives 6:2 chlorinated polyfluorinated ether sulfonate (6:2 Cl-PFESA) and 8:2 chlorinated polyfluorinated ether sulfonate (8:2 Cl-PFESA), were higher in the e-waste recycling area than in the general exposure area. In contrast, the median exposure levels of short-chain perfluoropentanoic acid (PFPeA) and perfluorohexanoic acid (PFHxA), as well as perfluorooctanoic acid (PFOA) branched isomers, including perfluoro-6-methylheptanoic acid (iso-PFOA), perfluoro-5-methylheptanoic acid (5m-PFOA), and perfluoro-4-methylheptanoic acid (4m-PFOA), were lower in the e-waste recycling area than in the general exposure area (P<0.05). The multiple linear regression models showed that, compared to the general exposure area, neonatal cord blood in the e-waste recycling area had significantly higher exposure levels of long-chain PFDA, PFUnDA, PFDoDA, PFTrDA, and emerging alternatives 6:2 Cl-PFESA and 8:2 Cl-PFESA, with odds ratios of 1.95 (95%CI: 1.39-2.75), 2.10 (95%CI: 1.58-2.75), 2.12 (95%CI: 1.39-3.25), 2.64 (95%CI: 1.63-4.22), 3.46 (95%CI: 2.34-5.10), and 3.25 (95%CI: 2.01-5.26), respectively. Conversely, the exposure levels of short-chain PFPeA, PFHxA, and branched PFOA (br-PFOA) were significantly lower, with odds ratios of 0.44 (95%CI: 0.38-0.52), 0.30 (95%CI: 0.16-0.57), and 0.50 (95%CI: 0.38-0.67), respectively.
PFAS are widely present in neonatal cord blood in both the e-waste recycling area and the general exposure area. Compared to the general exposure area, the neonatal cord blood samples in the e-waste recycling area show higher exposure levels of certain long-chain perfluoroalkyl carboxylic acids (PFCA) and emerging PFAS alternatives, while the neonatal cord blood samples in the general exposure area show higher exposure levels of some short-chain PFCA and PFOA branched isomers.
[1] |
BUCK R C, FRANKLIN J, BERGER U, et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins[J]. Integr Environ Assess Manag, 2011, 7(4): 513-541. doi: 10.1002/ieam.258
|
[2] |
GLÜGE J, SCHERINGER M, COUSINS I T, et al. An overview of the uses of per- and polyfluoroalkyl substances (PFAS)[J]. Environ Sci: Process Impacts, 2020, 22(12): 2345-2373. doi: 10.1039/D0EM00291G
|
[3] |
PANIERI E, BARALIC K, DJUKIC-COSIC D, et al. PFAS molecules: a major concern for the human health and the environment[J]. Toxics, 2022, 10(2): 44. doi: 10.3390/toxics10020044
|
[4] |
SUNDERLAND E M, HU X C, DASSUNCAO C, et al. A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects[J]. J Expo Sci Environ Epidemiol, 2019, 29(2): 131-147. doi: 10.1038/s41370-018-0094-1
|
[5] |
CONVENTION S. The new POPs under the Stockholm Convention [EB/OL]. (2023-05)[2024-07-05]. https://pops.int/theconvention/thepops/thenewpops/tabid/2511/default.aspx .
|
[6] |
BRENNAN N M, EVANS A T, FRITZ M K, et al. Trends in the regulation of per- and polyfluoroalkyl substances (PFAS): a scoping review[J]. lnt J Environ Res Public Health, 2021, 18(20): 10900. doi: 10.3390/ijerph182010900
|
[7] |
ATEIA M, MAROLI A, THARAYIL N, et al. The overlooked short- and ultrashort-chain poly- and perfluorinated substances: a review[J]. Chemosphere, 2019, 220: 866-882. doi: 10.1016/j.chemosphere.2018.12.186
|
[8] |
WANG Y, CHANG W, WANG L, et al. A review of sources, multimedia distribution and health risks of novel fluorinated alternatives[J]. Ecotoxicol Environ Saf, 2019, 182: 109402. doi: 10.1016/j.ecoenv.2019.109402
|
[9] |
WANG S, HUANG J, YANG Y, et al. First report of a Chinese PFOS alternative overlooked for 30 years: its toxicity, persistence, and presence in the environment[J]. Environ Sci Technol, 2013, 47(18): 10163-10170. doi: 10.1021/es401525n
|
[10] |
LIN S, ALI M U, ZHENG C, et al. Toxic chemicals from uncontrolled e-waste recycling: exposure, body burden, health impact[J]. J Hazard Mater, 2022, 426: 127792. doi: 10.1016/j.jhazmat.2021.127792
|
[11] |
TANSEL B. PFAS use in electronic products and exposure risks during handling and processing of e-waste: a review[J]. J Environ Manage, 2022, 316: 115291. doi: 10.1016/j.jenvman.2022.115291
|
[12] |
GARG S, KUMAR P, MISHRA V, et al. A review on the sources, occurrence and health risks of per-/poly-fluoroalkyl substances (PFAS) arising from the manufacture and disposal of electric and electronic products[J]. J Water Process Eng, 2020, 38: 101683. doi: 10.1016/j.jwpe.2020.101683
|
[13] |
ZHANG B, HE Y, HUANG Y, et al. Novel and legacy poly- and perfluoroalkyl substances (PFASs) in indoor dust from urban, industrial, and e-waste dismantling areas: the emergence of PFAS alternatives in China[J]. Environ Pollut, 2020, 263: 114461. doi: 10.1016/j.envpol.2020.114461
|
[14] |
PENG L, XU W, ZENG Q, et al. Exposure to perfluoroalkyl substances in waste recycling workers: distributions in paired human serum and urine[J]. Environ Int, 2022, 158: 106963. doi: 10.1016/j.envint.2021.106963
|
[15] |
ZHANG T, ZHANG B, BAI X, et al. Health status of elderly people living near E-waste recycling sites: association of E-waste dismantling activities with legacy perfluoroalkyl substances (PFASs)[J]. Environ Sci Technol Lett, 2019, 6(3): 133-140. doi: 10.1021/acs.estlett.9b00085
|
[16] |
WU K, XU X, PENG L, et al. Association between maternal exposure to perfluorooctanoic acid (PFOA) from electronic waste recycling and neonatal health outcomes[J]. Environ Int, 2012, 48: 1-8. doi: 10.1016/j.envint.2012.06.018
|
[17] |
ZHANG B, WEI Z, GU C, et al. First evidence of prenatal exposure to emerging poly- and perfluoroalkyl substances associated with E-waste dismantling: chemical structure-based placental transfer and health risks[J]. Environ Sci Technol, 2022, 56(23): 17108-17118. doi: 10.1021/acs.est.2c05925
|
[18] |
RAPPAZZO K M, COFFMAN E, HINES E P. Exposure to perfluorinated alkyl substances and health outcomes in children: a systematic review of the epidemiologic literature[J]. Int J Environ Res Public Health, 2017, 14(7): 691. doi: 10.3390/ijerph14070691
|
[19] |
高雪嫣, 王雨昕, 李敬光, 等. 天津市孕妇全氟有机化合物的暴露水平[J]. 中国卫生工程学, 2019, 18(2): 166-170.
GAO X Y, WANG Y X, LI J G, et al. Exposure of perfluoroalkyl substances in serum of pregnant women in Tianjin[J]. Chin J Public Health Eng, 2019, 18(2): 166-170.
|
[20] |
SAGIV S K, RIFAS-SHIMAN S L, WEBSTER T F, et al. Sociodemographic and perinatal predictors of early pregnancy per- and polyfluoroalkyl substance (PFAS) concentrations[J]. Environ Sci Technol, 2015, 49(19): 11849-11858. doi: 10.1021/acs.est.5b02489
|
[21] |
KINGSLEY S L, ELIOT M N, KELSEY K T, et al. Variability and predictors of serum perfluoroalkyl substance concentrations during pregnancy and early childhood[J]. Environ Res, 2018, 165: 247-257. doi: 10.1016/j.envres.2018.04.033
|
[22] |
INOUE K, RITZ B, ANDERSEN S L, et al. Perfluoroalkyl substances and maternal thyroid hormones in early pregnancy; findings in the Danish national birth cohort[J]. Environ Health Perspect, 2019, 127(11): 117002. doi: 10.1289/EHP5482
|
[23] |
ITOH S, ARAKI A, MIYASHITA C, et al. Association between perfluoroalkyl substance exposure and thyroid hormone/thyroid antibody levels in maternal and cord blood: the Hokkaido Study[J]. Environ Int, 2019, 133: 105139. doi: 10.1016/j.envint.2019.105139
|
[24] |
LIU J, LI J, LIU Y, et al. Comparison on gestation and lactation exposure of perfluorinated compounds for newborns[J]. Environ Int, 2011, 37(7): 1206-1212. doi: 10.1016/j.envint.2011.05.001
|
[25] |
ZHANG T, SUN H, QIN X, et al. PFOS and PFOA in paired urine and blood from general adults and pregnant women: assessment of urinary elimination[J]. Environ Sci Pollut Res Int, 2015, 22(7): 5572-5579. doi: 10.1007/s11356-014-3725-7
|
[26] |
LI J, YAO J, XIA W, et al. Association between exposure to per- and polyfluoroalkyl substances and blood glucose in pregnant women[J]. Int J Hyg Environ Health, 2020, 230: 113596. doi: 10.1016/j.ijheh.2020.113596
|
[27] |
中华人民共和国生态环境部. 重点管控新污染物清单(2023年版)[EB/OL]. [2023-12-22]. https://www.mee.gov.cn/gzk/gz/202212/t20221230_1009192.shtml.
LTD E A by E. China issues 2023 list of key controlled new pollutants | enviliance asia[EB/OL] [2024–07–05]. https://enviliance.com/regions/east-asia/cn/report_8936.
|
[28] |
DU D, LU Y, ZHOU Y, et al. Perfluoroalkyl acids (PFAAs) in water along the entire coastal line of China: spatial distribution, mass loadings, and worldwide comparisons[J]. Environ Int, 2022, 169: 107506. doi: 10.1016/j.envint.2022.107506
|
[29] |
HASHMI M Z, CHEN K, KHALID F, et al. Forty years studies on polychlorinated biphenyls pollution, food safety, health risk, and human health in an e-waste recycling area from Taizhou city, China: a review[J]. Environ Sci Pollut Res, 2022, 29(4): 4991-5005. doi: 10.1007/s11356-021-17516-0
|
[30] |
ZHAO L, CHENG Z, ZHU H, et al. Electronic-waste-associated pollution of per- and polyfluoroalkyl substances: environmental occurrence and human exposure[J]. J Hazard Mater, 2023, 451: 131204. doi: 10.1016/j.jhazmat.2023.131204
|
[31] |
HE Y, LV D, LI C, et al. Human exposure to F-53B in China and the evaluation of its potential toxicity: an overview[J]. Environ Int, 2022, 161: 107108. doi: 10.1016/j.envint.2022.107108
|
[32] |
PAN Y, ZHU Y, ZHENG T, et al. Novel chlorinated polyfluorinated ether sulfonates and legacy per-/polyfluoroalkyl substances: placental transfer and relationship with serum albumin and glomerular filtration rate[J]. Environ Sci Technol, 2017, 51(1): 634-644. doi: 10.1021/acs.est.6b04590
|
[33] |
SHI Y, VESTERGREN R, XU L, et al. Human exposure and elimination kinetics of chlorinated polyfluoroalkyl ether sulfonic acids (Cl-PFESAs)[J]. Environ Sci Technol, 2016, 50(5): 2396-2404. doi: 10.1021/acs.est.5b05849
|